![]() ![]() ![]() Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter.Noteworthy Mentions In Today's 52-Week Lows: Pfizer (NYSE:PFE) is the largest company in terms of market cap to set a new 52-week low thi Monkeypox Is No Longer a Global Health Emergency – WHOĪ̂ Thursday's session saw 189 companies set new 52-week lows. This is a 164.71 percent decrease over earnings of $0.34 per share from the same pĬo-Diagnostics GAAP EPS of -$0.20 Beats by $0.03, Revenue of $0.61M Misses by $0.49MĮarnings Flash (CODX) CO-DIAGNOSTICS Posts Q1 Revenue $600,000Ġ4:01 PM EDT, (MT Newswires) - Earnings Flash (CODX) CO-DIAGNOSTICS Posts Q1 Revenue $600,000 (NYSE:SPB) to posĬo-Diagnostics Q1 EPS $(0.22), Inline, Sales $601.96K Miss $1.10M EstimateĬo-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.22) per share which met the analyst consensus estimate. A decrease of -62.39 compared to the previous months estimate. With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:Wall Street expects Spectrum Brands Holdings, Inc. In January 2025 analysts predict a stock price of 0.51. Spectrum Brands, Sanmina And 3 Stocks To Watch Heading Into Friday NASDAQ Health Care/Life Sciences Compare to Open 1.10 Prior Close 1.09 (06/01/23) 1 Day CODX 0.00 DJIA 2.12 Russell 2K 3.56 Health Care/Life Sciences 3.31 Overview Per-Share Earnings, Actuals. WainwrightĬo-Diagnostics Has Received A Decision To Grant European Patent Number Ep3856931 Titled "Allele-Specific Design Of Cooperative Primers For Improved Nucleic Acid Variant Genotyping" analyst Yi Chen reiterates Co-Diagnostics with a Neutral and maintains $3 price target.Ĭo-Diagnostics (CODX) Receives a Hold From H.C. Reiterates Neutral on Co-Diagnostics, Maintains $3 Price Target ![]() If you are good with personal finance and are looking to invest, you will find the Co-Diagnostics on NASDAQ stock exchange.HC Wainwright & Co. ![]() Always read up on optimal investment strategies if you are new to investing. Trading in bear markets is always harder so you might want to avoid these stocks if you are not a veteran. Since this share has a negative outlook we recommend looking for other projects instead to build a portfolio. Our Ai stock analyst implies that there will be a negative trend in the future and the CODX shares are not a good investment for making money. Currently there seems to be a trend where stocks in the Healthcare Manufacturing sector(s) are not very popular in this period. Recommendations: Buy or sell Co-Diagnostics stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Co-Diagnostics share forecasts, stock quote and buy / sell signals below. Petros Pharmaceuticals Stock Forecast, 'PTPI' Share Price Prediction Charts Is 'Petros Pharmaceuticals Inc' a Good Investment Current price today: 0.951 USD (-2. (NASDAQ:CODX) Issued By Litchfield Hills Research. Home US Stock Forecast Petros Pharmaceuticals Inc Search Crypto, Currency Pair (FX), Stock, Commodity. Real Estate and Housing Market Forecast Q1 2023 Earnings Forecast for Co-Diagnostics, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |